跳至主要内容
临床试验/EUCTR2019-000902-31-ES
EUCTR2019-000902-31-ES进行中(未招募)1 期

Healing efficacy after impacted mandibular third molar surgery with the use of autologous platelet-rich fibrin: a randomized controlled clinical study

OMEQUI0 个研究点目标入组 36 人开始时间: 2019年7月5日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients> 18 years.
  • Presence of oral health (periodontally healthy or with treated periodontitis), with a BoP <20% and a PI <20%.
  • Systemically healthy, without any disease that may contraindicate minor oral surgery, that does not take any medication that may influence coagulation and / or that takes any NSAID or paracetamol daily.
  • Non-smokers or smokers of <10 cigarettes/day.
  • No pregnancy or lactation.
  • The tooth to be extracted will be included or semi-included and will have fully formed roots.
  • Absence of infectious and cystic pathology in the molar to be extracted.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 36
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients who due to systemic conditions are not possible to draw blood.
  • Penicillin allergy.
  • Allergy to ibuprofen and / or paracetamol.
  • Diseases that limit the use of ibuprofen and / or paracetamol.

研究者

发起方
OMEQUI

相似试验